Brief: Codiak Biosciences Announces FDA Clearance Of IND For exoASO™-Stat6 Patient Dosing Expected 1H 2022
30/11/2021 14:01
Nov 30 (Reuters) - Codiak BioSciences, Inc. CDAK.O :
* CODIAK BIOSCIENCES ANNOUNCES FDA CLEARANCE OF IND FOR
EXOASO™-STAT6; PATIENT DOSING EXPECTED 1H 2022
Source text for Eikon: ID:nGNX8qlFm1
Further company coverage: CDAK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Codiak BioSciences,.
See all newsBrief: Codiak Biosciences Notice From Listing Qualifications Department Of Nasdaq Trading Of Co's Common Stock To Be Suspended At Opening Of Business On April 5
U.S. STOCKS ON THE MOVE-Energy firms, crypto stocks, Walt Disney
U.S. STOCKS ON THE MOVE-Cyclerion, banks, Jounce Therapeutics
U.S. STOCKS ON THE MOVE-Tesla, BrainStorm, Pinterest
Codiak BioSciences down after co files for Chapter 11 bankruptcy